🔎 Trials Near Me

Home › Acute Monocytic Leukemia

Acute Monocytic Leukemia clinical trials recruiting in the U.S.

8 studies for Acute Monocytic Leukemia are recruiting participants at sites across the United States.

Cities with the most studies

By state

Recently updated studies

Decitabine With Ruxolitinib, Fedratinib or Pacritinib for the Treatment of Accelerated/Blast Phase Myeloproliferative Neoplasms

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT04282187

Fractionated Gemtuzumab Ozogamicin in Treating Measurable Residual Disease in Patients With Acute Myeloid Leukemia

RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 13, 2026 · NCT03737955

Halt Aging in Survivors of Blood Cancers

Recruiting
Ages 50 and older · All sexes · Updated Jul 1, 2026 · NCT07292272

A Phase 1 Study of STX-0712 in Patients With Advanced Hematological Malignancies (CMML and AML)

RecruitingPhase 1
Ages 18 and older · All sexes · Updated Feb 9, 2026 · NCT06950034

Mitoxantrone for Venetoclax Resistant Acute Myeloid Leukemia

RecruitingPhase 1
Ages 18 to 80 · All sexes · Updated Jan 15, 2026 · NCT06429449

From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.